Genetic Testing in Liver Disease

by | Mar 19, 2025 | Uncategorized

Researchers indicate that disease characteristics consistent with ABCB4 mutations “should be considered when facing cholestasis of unclear etiology,” or cause. The case study, “Unveiling the Genetic Culprit: A Diagnostic Dilemma of Recurrent Cholestasis With...

Rise in MASLD Burden

by | Mar 15, 2025 | Uncategorized

Here at LiverRight, we believe in swift access to diagnosis and care for adults who might be at risk for liver disease, via same-week video visits. Across all 50 US states. From the Gastroenterology Learning Network 03/14/2025 article by Jessica Garlewicz, titled...

Efruxifermin reverses MASH-related cirrhosis in Phase 2

by | Mar 12, 2025 | Uncategorized

Efruxifermin reverses MASH-related cirrhosis in Phase 2 trial, per a recent press release from Akero Therapeutics. Treatment with Akero Therapeutics’ investigational efruxifermin led to reversals of compensated cirrhosis, or irreversible scarring in a...

Hepatitis B (“HBV”) Explainer Video

by | Mar 8, 2025 | Uncategorized

From McMaster University: “As the most common liver disease in the world, Hepatitis B is a life-threatening liver infection caused by the hepatitis B virus, or HBV. It can cause chronic infection and put people at a high risk of death from cirrhosis (scarring of...